Angiotensin-(1-7) attenuates metastatic prostate cancer and reduces osteoclastogenesis

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Inhibition of Prostate Cancer Osteoblastic Progression with VEGF121/rGel, a Single Agent Targeting Osteoblasts, Osteoclasts, and Tumor Neovasculature

(2011) K. A. Mohamedali et al.   CLINICAL CANCER RESEARCH

New developments for treatment and prevention of bone metastases

(2011) Jean-Jacques Body   CURRENT OPINION IN ONCOLOGY

Novel Therapeutic Strategies for Castration Resistant Prostate Cancer: Inhibition of Persistent Androgen Production and Androgen Receptor Mediated Signaling

(2011) Arturo Molina et al.   JOURNAL OF UROLOGY

Advances in the biology of bone metastasis: How the skeleton affects tumor behavior

(2010) Julie A. Sterling et al.   BONE

Pathogenesis of osteoblastic bone metastases from prostate cancer

(2010) Toni Ibrahim et al.   CANCER

Anti-Placental Growth Factor Reduces Bone Metastasis by Blocking Tumor Cell Engraftment and Osteoclast Differentiation

(2010) L. Coenegrachts et al.   CANCER RESEARCH

Angiotensin-(1-7) Reduces Fibrosis in Orthotopic Breast Tumors

(2010) K. L. Cook et al.   CANCER RESEARCH

Androgen hypersensitivity in prostate cancer: Molecular perspectives on androgen deprivation therapy strategies

(2010) Ruth Foley et al.   PROSTATE

Examining the Metastatic Niche: Targeting the Microenvironment

(2010) Theresa Guise   SEMINARS IN ONCOLOGY

Novel Targeted Therapies for Prostate Cancer

(2010) Robyn J. Macfarlane et al.   UROLOGIC CLINICS OF NORTH AMERICA

Role of the VEGF-Flt-1-FAK pathway in the pathogenesis of osteoclastic bone destruction of giant cell tumors of bone

(2010) Yoshihiro Matsumoto et al.   Journal of Orthopaedic Surgery and Research

Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival Signals

(2009) Xiang H.-F. Zhang et al.   CANCER CELL

Phase I and Pharmacokinetic Study of Angiotensin-(1-7), an Endogenous Antiangiogenic Hormone

(2009) W. J. Petty et al.   CLINICAL CANCER RESEARCH

The critical role of the bone microenvironment in cancer metastases

(2009) Sandra Casimiro et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor

(2009) D. R. Soto-Pantoja et al.   MOLECULAR CANCER THERAPEUTICS

Vascular endothelial growth factor regulates osteoblast survival – evidence for an autocrine feedback mechanism

(2009) John Street et al.   Journal of Orthopaedic Surgery and Research

Mechanisms of bone metastasis in prostate cancer: clinical implications

(2008) Pavlos Msaouel et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

VEGF enhancement of osteoclast survival and bone resorption involves VEGF receptor-2 signaling and β3-integrin

(2008) Q YANG et al.   MATRIX BIOLOGY

Cadherin-11 Promotes the Metastasis of Prostate Cancer Cells to Bone

(2008) K. Chu et al.   MOLECULAR CANCER RESEARCH